Key statistics
On Tuesday, Lipocine Inc (LPCN:NAQ) closed at 5.30, 129.43% above the 52 week low of 2.31 set on Oct 30, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 5.10 |
---|---|
High | 5.49 |
Low | 4.90 |
Bid | 5.06 |
Offer | 8.47 |
Previous close | 4.99 |
Average volume | 20.66k |
---|---|
Shares outstanding | 5.35m |
Free float | 5.19m |
P/E (TTM) | -- |
Market cap | 28.34m USD |
EPS (TTM) | -1.60 USD |
Data delayed at least 15 minutes, as of Oct 08 2024 21:00 BST.
More ▼
Press releases
- Lipocine Announces Supply and Distribution Agreement with Pharmalink to Commercialize TLANDO® in the Gulf Cooperation Council (GCC) Countries
- Lipocine to Host Virtual KOL Event on LPCN 2401 for Improved Body Composition in Obesity Management on October 16, 2024
- Lipocine to Present at H.C. Wainwright 8th Annual MASH Investor Conference
- Lipocine Announces Phase 2 Data on LPCN 2401 to be Presented at ObesityWeek®
- Lipocine to Present at H.C. Wainwright 26th Annual Global Investment Conference
- Lipocine Announces Financial Results for the Second Quarter Ended June 30, 2024
More ▼